Rooibos.

Rooibos carries flavonoids that bind non-heme iron, though at a lower tannin load than Camellia sinensis tea. Ascorbate taken in the same meal reduces iron to the ferrous form and offsets part of that binding. The chemistry is the same one described for tea and coffee. It applies at the level of a single meal.

Rooibos is often chosen as the low-tannin alternative to black tea, and its measured effect on non-heme iron uptake is smaller. Smaller is not zero: the flavonoids present still bind iron in the gut. Spacing an iron supplement from the drink by an hour or two removes the question. The practical difference from black tea is one of degree.

Part of the flavonol content of rooibos is quercetin already, bound to sugars and released by gut microbial glycosidases before absorption. Adding a quercetin supplement adds to the same pool rather than introducing a new mechanism. Total intake should be counted across both. There is no reason to expect an interaction beyond addition.

Rooibos is used as a caffeine-free base precisely because the plant makes none, unlike Camellia sinensis. A blend that adds caffeine to rooibos removes the main reason people reach for it. Formulators generally keep the two apart for that reason. The point is product design, not pharmacology.

Both contribute polyphenols that bind non-heme iron, so combining them raises the total binding in a meal above either alone. The two differ in profile: rooibos brings dihydrochalcones and quercetin glycosides, green tea brings catechins. Green tea also brings caffeine, which rooibos does not. Count the caffeine from the green tea side.

A dietary study in animals fed n-3 fatty acids alongside rooibos looked at reproductive tissue outcomes and fatty acid composition. Polyphenols slowing oxidation of long-chain polyunsaturated fats is a plausible chemical rationale for pairing them. This is animal work and does not carry over to a human outcome. Read it as a reason to look further, not as a finding in people.

One rodent study fed red rooibos against a background diet low in vitamin D and calcium and measured a behavioural readout. The design tells you something about the interaction of the plant with a poor mineral background, not about supplementing a person who is already replete. Species and diet both differ from human use. It stays mechanistic until a human trial exists.

Rodent studies of green and red rooibos have used bone and mineral endpoints against controlled dietary calcium backgrounds. The plant's flavonoids can also bind divalent cations in the gut, which is a separate and opposing consideration. Both threads are animal or chemical. Neither establishes anything about bone in people.

Flavonoids bind zinc as well as iron, though the effect is smaller and less well characterised. A zinc supplement taken with a strong rooibos infusion meets a partly binding partner. Spacing them is the simple answer. This is lumen chemistry, not a statement about zinc status.

People sometimes assume a herbal tea brings theanine because green tea does. Rooibos does not make it. If theanine is wanted alongside a caffeine-free base, it has to be added as an ingredient. The pairing is formulation, with no shared plant chemistry behind it.

Water-soluble flavonoids can regenerate oxidised tocopherol at the lipid-water interface in cell-free systems. Rooibos flavonoids behave in this class. The relevance is to oxidation of the formulation and to test-tube measures. It has not been shown to change any measured outcome in a person.